Mitigating Risk in Pathogen Safety- An Interview with Jürgen Blusch
Add bookmark
Mitigating Risk in Pathogen Safety- An Interview with Jürgen Blusch
Add bookmarkJürgen Blusch, Head of Cell Substrate Analytics at Novartis speaks to Pharma IQ on the topics of mitigating risk in pathogen safety, new technologies and techniques such as nucleic acid based techniques for safety testing. He also spoke about what is limiting the uptake of these promising techniques.
[inlinead]
Tags:
Jürgen Blusch
Novarits
pathogen safety
Cell Substrate Analytics
mitigating risk in pathogen safety
